Lockheed Martin Launches Healthcare Technology Alliance
News Jul 31, 2015
The Lockheed Martin Healthcare Technology Alliance’s founding members include: Cisco, Cloudera, Illumina, Intel and Montgomery College.
“Federal health IT is a dynamic and growing sector,” said Horace Blackman, vice president of Health & Life Sciences at Lockheed Martin. “Through collaboration between health IT industry and academic partners, this team will develop and refine technologies that will help guide decisions for care, diagnosis and treatment of disease while protecting critical health information.”
The members of the Lockheed Martin Healthcare Technology Alliance will collaborate on technology solutions that help improve care in rapidly evolving and growing areas of health technology such as those that: secure patient medical information; leverage advances in genomic research; and apply big data solutions to improve public health.
Alliance partners are already making progress on complex health information technology solutions. Lockheed Martin and Illumina are collaborating to develop tailored solutions for national-scale genomicsprograms. Lockheed Martin systems integration and data analytics experience compliments Illumina's recognized leadership in genomic sequencing and analysis. This collaboration has the potential to create a complete offering for customers — the most advanced tools and best practices in large-scale genomic solutions.
“We are so pleased to be a part of this forward-thinking alliance; joining industry and academic research is the best way to spark innovation,” said Dr. DeRionne P. Pollard, president of Montgomery College. “Together, we can do great things.”
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE